Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2003
06/05/2003WO2003046129A2 Compositions for the derivation of germ cells from stem cells and methods of use thereof
06/05/2003WO2003046124A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003WO2003046009A1 ANTI-IL13 RECEPTOR α1 NEUTRALIZING ANTIBODY
06/05/2003WO2003045999A2 Human vanilloid receptor protein and polynucleotide sequence encoding same
06/05/2003WO2003045995A2 Cell culture process
06/05/2003WO2003045989A1 A novel homeobox gene
06/05/2003WO2003045459A1 Milk protein biofilm and uses thereof
06/05/2003WO2003045458A1 Method for improving functionality of tissue constructs
06/05/2003WO2003045438A1 Increasing electro-gene transfer of nucleic acid molecules into host tissue
06/05/2003WO2003045431A2 Methods for treating cancer using a combination of a tumor-derived dendritic cell inhibitory factor antagonist and a toll-like receptor agonist
06/05/2003WO2003045427A2 Pharmaceutical composition for inducing an immune response in a human or animal
06/05/2003WO2003045335A2 Stem cell screening and transplantation therapy for hiv infection
06/05/2003WO2003045318A2 Manipulation of cytokine levels using cd83 gene products
06/05/2003WO2003045317A2 Therapeutic protein and treatments
06/05/2003WO2003045312A2 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin
06/05/2003WO2003045304A2 Mutable vaccines
06/05/2003WO2003045230A2 Novel compositions and methods for cancer
06/05/2003WO2003045226A2 Eb matrix production from animal tissue and its use for tissue repair
06/05/2003WO2003045136A1 Disruption of the prostaglandin e synthase 2 gene
06/05/2003WO2003029418A3 Proliferation and differentiation of stem cells using extracellular matrix and other molecules
06/05/2003WO2003020908A3 Multi-lineage directed induction of bone marrow stromal cell differentiation
06/05/2003WO2003010201A9 Blood group antigen fusion polypeptides and methods of use thereof
06/05/2003WO2002081665A3 Implantation serine proteinases
06/05/2003WO2002081007A3 Methods of isolating blood components using a centrifuge and uses thereof
06/05/2003WO2002077261A3 Human potassium channel
06/05/2003WO2002062841A3 Secreted proteins
06/05/2003WO2002060932A3 A serpin in bifidobacteria
06/05/2003WO2002046230A3 G-protein coupled receptors
06/05/2003WO2002042330A3 Cystoskeleton-associated proteins
06/05/2003WO2002030965A3 Nucleic acids encoding stichodactylidae chromoproteins
06/05/2003WO2002014478A3 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY
06/05/2003US20030106109 Raphanus with increased anthocyanin levels
06/05/2003US20030106104 Antiapoptosis; antisense agents; regulation of seed aging in tomatoes; stress resistance; prolonged viability and shelf-life
06/05/2003US20030106103 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
06/05/2003US20030106102 Antiapoptosis; antisense agents; regulation of seed aging in tomatoes; stress resistance; prolonged viability and shelf-life
06/05/2003US20030106101 Antiapoptosis; antisense agents; regulation of seed aging in tomatoes; stress resistance; prolonged viability and shelf-life
06/05/2003US20030106100 DNA molecules encoding enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing these molecules
06/05/2003US20030106097 Hydrolases; insect/disease resistant plants; controlling cellulose concentration during cell wall deposition
06/05/2003US20030106094 Disease and insect resistant plants; biological pest control
06/05/2003US20030106093 Coleoptera resistant plants; biological pest control
06/05/2003US20030106090 Materials and methods for the alteration of enzyme and acetyl CoA levels in plants
06/05/2003US20030106088 Transduction for expression of heterologous proteins in phloem; disease resistant plants; cry proteins; bactericides
06/05/2003US20030106085 Disruption of the prostaglandin E synthase 2 gene
06/05/2003US20030106082 Transgenic stem cells, formed by dissociating blastomeres, are cultured, impregnated within surrogate; animals models; gene therapy
06/05/2003US20030106081 Transferring dipolid nucleus arrested oocyte in metaphase of meiosis for regeneration of animals embryos/cloning
06/05/2003US20030106079 Immunologically defective rat cells; tumorigenesis
06/05/2003US20030106078 mcFP encoding nucleic acids, polypepetides, antibodies and mehods of use thereof
06/05/2003US20030106077 Transfection of noncircular vector into stem cell genome by way of homologous recombination; gene therapy
06/05/2003US20030106075 Novel gene encoding organic anion transporter
06/05/2003US20030105318 G-protein transmembrane domain; protein synthesis inhibitor; neurotransmitter
06/05/2003US20030105292 Continously induced g-protein coupled receptors; membrane binding assays
06/05/2003US20030105288 Membrane proteins; antitumor agents; antiproliferative agents; tumor necrosis factor
06/05/2003US20030105285 Odorant receptors
06/05/2003US20030105284 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
06/05/2003US20030105277 Tat transport proteins; antiproliferative agents; antitumor agents
06/05/2003US20030105058 CD44-like protein
06/05/2003US20030105057 Modulating the rate and/or amount of a cellular process selected from the group consisting of cell growth, cell detachment and cell migration, and cellular apoptosis by altering the RECEPTOR/PTK-STAT pathway of cell
06/05/2003US20030105044 Antisense modulation of matrix metalloproteinase 1 expression
06/05/2003US20030105040 Antisense modulation of inhibitor-kappa B-R expression
06/05/2003US20030105036 Antisense Inhibition of vascular endothelial growth factor receptor-1 expression
06/05/2003US20030105024 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
06/05/2003US20030105013 For therapy of wounds, various cancers, and disorders of the vessels including atherosclerosis and cardiac hypertrophy
06/05/2003US20030105012 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
06/05/2003US20030105011 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
06/05/2003US20030105006 For therapy of bacterial infections
06/05/2003US20030104998 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104997 Contacting the formed endodermal/neuronal precursor cell with endodermal differentiation-inducing compound; insulin-secreting pancreatic islet cell, transfecting cell for gene therapy
06/05/2003US20030104970 Modulating the growth state of an epithelial cell by ectopically contacting the epithelial cell, in vitro or in vivo, with hedgehog polypeptide or patched therapeutic to promote or inhibit of proliferation of epithelial cell
06/05/2003US20030104626 Packaging systems for human recombinant adenovirus to be used in gene therapy
06/05/2003US20030104624 Novel vector constructs
06/05/2003US20030104623 Transduction of conjugate polypeptides into tissues
06/05/2003US20030104620 Expression vector for expression of heterologous polypeptides and amplification of cell viral resistance; viricides
06/05/2003US20030104619 Hypoxia-mediated neurogenesis
06/05/2003US20030104618 Retinal cell grafts
06/05/2003US20030104617 Layer vessel matrix for universal tissue building and device for incubation
06/05/2003US20030104616 Isolation of inner cell mass for the establishment of human embryonic stem cell (hESC) lines
06/05/2003US20030104615 Immortalized bone marrow mesenchymal stem cell
06/05/2003US20030104614 Apparatus for use in cell propagation; tissue regeneration
06/05/2003US20030104613 Amplification of cell proliferation using polyvinylpyrrolidone as activitor; antiapoptosis; genetically engineered tissue for the propagation of polio, rabies, hepatitis or rubella viruses
06/05/2003US20030104611 Feline immunodeficiency virus gene therapy vectors
06/05/2003US20030104602 Adipocyte complement related protein zacrp3X2
06/05/2003US20030104596 human desaturase gene and uses thereof
06/05/2003US20030104595 Oxidoreductase; probes for accurate measurement and detection of glucose concentration in cell
06/05/2003US20030104589 Tissue adhesive using synthetic crosslinking
06/05/2003US20030104579 Pluripotent stem cells; antitumor agents; antiproliferative agents; antiinflammatory agents; veterinary medicine; tissue engineering
06/05/2003US20030104577 Gag genes and gag protein; cell-free translation; transcriptases; viricides; enzyme inhibitors
06/05/2003US20030104575 Culturing keratinocytes; skin grafts; tissue engineering
06/05/2003US20030104569 Proteins suppressing proliferation of lympho-hematopoietic cells
06/05/2003US20030104568 Monitoring electrical transfer between transgenic cell and heart muscle tissue; electroconductivity analysis; tissue engineering
06/05/2003US20030104565 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104563 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104558 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104557 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptides; cancer diagnosis
06/05/2003US20030104556 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104555 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104554 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypetide; cancer diagnosis
06/05/2003US20030104552 For stimulating release of tumor necrosis factor and/or cellular prolifefration/differentiation/ of chondrocytes, by contacting blood with polypeptide; cancer diagnosis
06/05/2003US20030104551 For stimulating release of tumor necrosis factor and /or proliferation/differentiation of chondrocytes by contacting blood with polypeptides; cancer diagnosis
06/05/2003US20030104550 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104549 Secreted and transmembrane polypeptides and nucleic acids encoding the same